Production (Stage)
NLS Pharmaceutics AG
NLSP
$2.30
$0.2210.58%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 1.67M | 1.67M | 552.80K | 552.80K | 897.70K |
| Total Receivables | 449.50K | 449.50K | 81.00K | 81.00K | 35.10K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 45.40K | 45.40K | 297.30K | 297.30K | 69.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 65.20K | 65.20K | 261.40K | 261.40K | 821.30K |
| Total Current Assets | 2.23M | 2.23M | 1.19M | 1.19M | 1.82M |
|
|
|||||
| Total Current Assets | 2.23M | 2.23M | 1.19M | 1.19M | 1.82M |
| Net Property, Plant & Equipment | 7.30K | 7.30K | 1.00K | 1.00K | 6.70K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 300.00 | 300.00 | -- | -- | 16.90K |
| Total Assets | 2.23M | 2.23M | 1.19M | 1.19M | 1.85M |
|
|
|||||
| Total Accounts Payable | 515.50K | 515.50K | 4.58M | 4.58M | 4.63M |
| Total Accrued Expenses | 311.30K | 311.30K | 1.42M | 1.42M | 1.54M |
| Short-term Debt | -- | -- | 1.71M | 1.71M | 1.63M |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | 112.60K |
| Total Other Current Liabilities | -- | -- | -- | -- | 112.60K |
| Total Current Liabilities | 826.80K | 826.80K | 7.72M | 7.72M | 7.92M |
|
|
|||||
| Total Current Liabilities | 826.80K | 826.80K | 7.72M | 7.72M | 7.92M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | 1.71M | 1.71M | 1.63M |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | 2.74M | 2.74M | 2.76M |
| Total Liabilities | 826.80K | 826.80K | 10.46M | 10.46M | 10.68M |
|
|
|||||
| Common Stock & APIC | 72.99M | 72.99M | 63.14M | 63.14M | 61.70M |
| Retained Earnings | -74.43M | -74.43M | -72.41M | -72.41M | -70.37M |
| Treasury Stock & Other | 108.90K | 108.90K | 4.20K | 4.20K | -158.10K |
| Total Common Equity | -1.33M | -1.33M | -9.27M | -9.27M | -8.83M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 2.74M | 2.74M | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 2.74M | 2.74M | -- | -- | -- |
|
|
|||||
| Total Common Equity | -1.33M | -1.33M | -9.27M | -9.27M | -8.83M |
| Total Preferred Equity | 2.74M | 2.74M | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 1.41M | 1.41M | -9.27M | -9.27M | -8.83M |
|
|
|||||